■ A survey from Bausch Health Companies and the Glaucoma Research Foundation sought to understand patients’ concern around hyperemia associated with glaucoma drops, noting that dissatisfaction with side effects are among the primary reason for nonadherence and discontinuation of drops. With hyperemia as the most common documented side effect, some patients stop or skip medication as a result, according to a news release.

The survey of 101 glaucoma patients experiencing hyperemia “demonstrated that the emotional cost of hyperemia is high, with 71% of participants feeling self-conscious and 55% feeling embarrassed about their red eyes,” said Joe Gordon, US president of Bausch + Lomb, in a news release. “It is our hope that by raising awareness of this issue, we can help facilitate discussions among patients and their eye care professionals about their options and the importance of adhering to their treatment regimen.”